Publications by authors named "Harold Ballard"

Claim this Profile
S
Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.
Michael Auerbach, Jennifer A Pappadakis, Huzefa Bahrain, Sarah A Auerbach, Harold Ballard

Am J Hematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.
Dianne Pulte, Richard R Furman, M Johan Broekman, Joan H F Drosopoulos, Harold S Ballard

Clin Lymphoma Myeloma Leuk· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use of intravenous iron: administration, efficacy, and safety.
Michael Auerbach, Harold Ballard

Hematology Am Soc Hematol Educ Program· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma involving skin and pulmonary parenchyma after autologous stem cell transplantation.
Yuan Yuan, Rosemary Wieczorek, David L Green, Perry Cook, Harold Ballard

J Hematol Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approach to acute renal failure in biopsy proven myeloma cast nephropathy: is there still a role for plasmapheresis?
Luana Pillon, Raeshell S Sweeting, Avi Arora, Alicia Notkin, Harold S Ballard

Kidney Int· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous iron as standard of care in oncology: opportunity lost.
Michael Auerbach, Harold Ballard

J Am Pharm Assoc (2003)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous iron: from anathema to standard of care.
Michael Auerbach, Dan Coyne, Harold Ballard

Am J Hematol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous iron in oncology.
Michael Auerbach, Harold Ballard

J Natl Compr Canc Netw· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
Dianne Pulte, Kim E Olson, M Johan Broekman, Naziba Islam, Harold S Ballard

J Transl Med· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical update: intravenous iron for anaemia.
Michael Auerbach, Harold Ballard, John Glaspy

Lancet· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reexamination of the need for treatment in Idiopathic Thrombocytopenic Purpura.
Michael Auerbach, Harold Ballard

Am J Hematol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.
Michael Auerbach, Harold Ballard, J Richard Trout, Marilyn McIlwain, Alan Ackerman

J Clin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis